News

PIC's gene-edited pigs are highly resistant to one of the most harmful viruses affecting pig populations worldwide today.
Globally, people get animal protein mostly from chickens, with pigs and cattle in second and third place. A 2023 report ...
Shares of CRISPR Therapeutics (NASDAQ:CRSP) can’t seem to catch a break, now down close to 8% year to date and more than 80% ...
CRISPR Therapeutics and Intellia face 2025 volatility, but CRSP’s strong cash and launches make it more attractive than NTLA.
Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...
A first-in-human clinical trial tests a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers.
Scientists at Oak Ridge National Laboratory and the University of Colorado Boulder used a gene-silencing tool and a large ...
Hyderabad: In a landmark moment for Indian agricultural science, ICAR–Indian Institute of Rice Research (IIRR) at ...
Rebecca Buckley, David Robinson II and Feng Zhang will be recognized Sunday in Wallace Wade Stadium. Their professional ...
India has become the first country to develop genome-edited rice varieties, DRR Dhan 100 (Kamala) and Pusa DST Rice 1. These ...
Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes it worthwhile to examine what the stock has in store.
Unity Biotechnology and Mammoth Biosciences are bpth turning toward cost-saving measures, prompting layoffs at both companies ...